Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis

Autor: Que Zhang, Weijun Pang, Rui Cai, Wenlong Yong, Yingqian Wang, Rui Zhao
Rok vydání: 2021
Předmět:
Male
IGF2BP2
insulin-like growth factor 2 mRNA-binding protein 2

0301 basic medicine
Myoblast proliferation
Muscle Fibers
Skeletal

lnc-ORA
obesity-related lncRNA

lncRNAs
long noncoding RNAs

Muscle Development
MyoD
Biochemistry
Myoblasts
MAFbx
muscle atrophy F-box

Mice
AAV
adeno-associated virus

Myosin
Myocyte
MyoG
myogenin

Adipogenesis
Myogenesis
MyoD
myogenic differentiation 1

RNA-Binding Proteins
Cell Differentiation
RIP
RNA immunoprecipitation

insulin-like growth factor 2 mRNA-binding protein 2
Muscle atrophy
Cell biology
Muscular Atrophy
medicine.anatomical_structure
miR-532-3p
RNA
Long Noncoding

myogenesis
medicine.symptom
Signal Transduction
Research Article
MyHC
myosin heavy chain

Biology
KEGG
Kyoto Encyclopedia of Genes and Genomes

Dex
dexamethasone

03 medical and health sciences
GO
Gene Ontology

medicine
Animals
lnc-ORA
skeletal muscle
Muscle
Skeletal

silnc-ORA
siRNA-lnc-ORA

Molecular Biology
Myogenin
Cell Proliferation
MuRF1
muscle RING finger 1

030102 biochemistry & molecular biology
Skeletal muscle
Cell Biology
GAS
gastrocnemius

PTEN
phosphatase and tensin homolog

Mice
Inbred C57BL

MicroRNAs
PTEN/PI3K/AKT signaling pathway
030104 developmental biology
EdU
5-ethynyl-20-deoxyuridine

MRFs
myogenic regulatory factors

Proto-Oncogene Proteins c-akt
Zdroj: The Journal of Biological Chemistry
ISSN: 0021-9258
DOI: 10.1016/j.jbc.2021.100376
Popis: Skeletal muscle is one of the most important organs of the animal body. Long noncoding RNAs play a crucial role in the regulation of skeletal muscle development via several mechanisms. We recently identified obesity-related lncRNA (lnc-ORA) in a search for long noncoding RNAs that influence adipogenesis, finding it impacted adipocyte differentiation by regulating the PI3K/protein kinase B/mammalian target of rapamycin pathway. However, whether lnc-ORA has additional roles, specifically in skeletal muscle myogenesis, is not known. Here, we found that lnc-ORA was significantly differentially expressed with age in mouse skeletal muscle tissue and predominantly located in the cytoplasm. Overexpression of lnc-ORA promoted C2C12 myoblast proliferation and inhibited myoblast differentiation. In contrast, lnc-ORA knockdown repressed myoblast proliferation and facilitated myoblast differentiation. Interestingly, silencing of lnc-ORA rescued dexamethasone-induced muscle atrophy in vitro. Furthermore, adeno-associated virus 9–mediated overexpression of lnc-ORA decreased muscle mass and the cross-sectional area of muscle fiber by upregulating the levels of muscle atrophy–related genes and downregulating the levels of myogenic differentiation–related genes in vivo. Mechanistically, lnc-ORA inhibited skeletal muscle myogenesis by acting as a sponge of miR-532-3p, which targets the phosphatase and tensin homolog gene; the resultant changes in phosphatase and tensin homolog suppressed the PI3K/protein kinase B signaling pathway. In addition, lnc-ORA interacted with insulin-like growth factor 2 mRNA-binding protein 2 and reduced the stability of myogenesis genes, such as myogenic differentiation 1 and myosin heavy chain. Collectively, these findings indicate that lnc-ORA could be a novel underlying regulator of skeletal muscle development.
Databáze: OpenAIRE